Coeur D Alene Pharmaceuticals Company

The company revenue keeps increasing year by year, which means we are doing an excellent job and working hard to stay among the most valuable companies on the market

The annual revenue of Zylex Pharmaceuticals Inc has increased, being situated between $1.000.000 to $2.499.999

The strong foundation Oxyfresh Worldwide Inc is built on provides us the means of staying a few steps ahead of the competition every time. We value too much our team and our customers and this way, we manage to be one of the most appreciated companies in the Pharmaceuticals